TABLE 4.1.
Market Shares of Vaccine Companies, 2014
Company | Year-End Earnings ($ Billion)a | Market Share (%) |
---|---|---|
GlaxoSmithKline | 5.3 | 19.7 |
Merck & Co.b | 6.2 | 23.4 |
Novartis | 1.5 | 5.7 |
Pfizer | 4.5 | 16.8 |
Sanofi† | 5.8 | 21.9 |
Others | 3.4 | 12.6 |
Total | 26.7 | 100 |
Company 2014 year-end earnings releases from EvaluatePharma (http://www.evaluategroup.com).
Each includes 50% of revenues from Sanofi Pasteur MSD joint venture.